EBOS petcare bid falls over

Lack of enthusiasm from investors pegged as major factor in distributor withdrawing from Greencross purchase The anticipated $3.75 billion deal which would have seen pharmaceutical distributor EBOS buy up the pet company Greencross has stopped in its tracks after weak interest from investors. EBOS sent out a statement on Wednesday 22 November (2023) confirming that

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous WATCH: Risk management processes in pharmacy—compounding and beyond
Next 60-day dispensing hit staff morale